CE: Innovations in Acute Graft-Versus-Host Disease: Pharmacy Updates on Risk Assessment, Prevention, and Treatment

Pharmacy Times Oncology Edition, February 2021, Volume 3, Issue 1

This activity is supported by an educational grant from Incyte Corporation.

This activity is supported by an educational grant from Incyte Corporation.

EDUCATIONAL OBJECTIVES

At the completion of this activity, the participant will be able to:

  • Apply risk scoring tools for assessing grade and stage of acute graft-versus-host disease (aGVHD) in allogeneic hematopoietic stem cell transplantation (HSCT) recipients
  • Examine emerging strategies in the prevention and treatment of aGVHD
  • Maximize the role of the pharmacist of the HSCT team to improve patient outcomes

FACULTY

Nicole Watts, PharmD, BCOP

Clinical Pharmacy Specialist, Blood and Bone Marrow Transplant , University of Alabama at Birmingham Hospital , Birmingham, Alabama

TARGET AUDIENCE: Pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: November 30, 2020

EXPIRATION DATE: August 30, 2021

ESTIMATED TIME TO COMPLETE ACTIVITY: 2 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.